Item 7.01 Other Events.

Pliant Therapeutics, Inc. (the "Company") intends to conduct meetings with securities analysts, investors and others in connection with the 41st Annual J.P. Morgan Healthcare Conference beginning on January 9, 2023. As part of these meetings, the Company intends to utilize the corporate slide presentation furnished with this report as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.

Exhibit
  No.       Description

99.1          Corporate Slide Presentation dated January 9, 2023.

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document).

The information in this Item 7.01 is being furnished, not filed, pursuant to Regulation FD. Accordingly, the information in Item 7.01 of this report will not be incorporated by reference into any registration statement filed by the Company under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by reference. The furnishing of the information in this report is not intended to, and does not, constitute a determination or admission by the Company that the information in this report is material or complete, or that investors should consider this information before making an investment decision with respect to any security of the Company.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses